Live News Categoriesmarket

VOR.O (VOR.O) News

Follow VOR.O (VOR.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VOR.O Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 12:10 PM UTC Open live news feed

M Vor Biopharma telitacicept post hoc Phase 3 analysis: 42% minimal symptom expression through 48 weeks Vor Biopharma released a China Phase 3 post hoc analysis in generalized myasthenia gravis, reporting 42% minimal symptom expression and broad, sustained symptom relief through 48 weeks; safety was consistent with earlier EARNINGS | Sep 29, 2026, 12:10 PM UTC